NEW BRUNSWICK, N.J., March 13, 2020 /3BL Media/ – Johnson & Johnson today announced that its Janssen Pharmaceutical Companies have entered a collaboration with the Beth Israel Deaconess Medical Center (BIDMC) to support the development of a preventive vaccine candidate for COVID-19. The parties have commenced preclinical testing of multiple vaccine prospects, with the aim to identify by the end of the month a COVID-19 vaccine candidate for clinical trials.
It was 9pm, January 22, one day before the Spring Festival holiday.
Wang Donghua, a Johnson & Johnson China employee in Wuhan, the epicenter of the COVID-19 outbreak, received a message from Will Song, chairman of Johnson & Johnson China.
“Donghua, hope you and your family are well. We learnt the front-line hospitals urgently need protective gear, so the company decided to donate medical supplies to support the doctors and nurses. Can you please help facilitate the donation efforts as soon as possible? All the best.”
For International Women's Day, we’re taking a look at some of the ways the company has shown its commitment to women—from industry-leading employee benefits to life-changing innovations.
Article
For International Women's Day, we’re taking a look at some of the ways the company has shown its commitment to women—from industry-leading employee benefits to life-changing innovations.
The early data results seemed almost too good to be true.
That's what Sen Zhuang, M.D., Ph.D., Vice President, Oncology Clinical Research, Janssen Research & Development, was thinking at a meeting of the American Society of Clinical Oncology (ASCO) last summer.
A new report from the American Cancer Society sheds light on declining death rates from cancer—especially lung cancer. We asked an expert on the disease to break down the data, and share what's to come in better detecting and preventing it.
Article
A new report from the American Cancer Society sheds light on declining death rates from cancer—especially lung cancer. We asked an expert on the disease to break down the data, and share what's to come in better detecting and preventing it.
For decades, Johnson & Jonson has been partnering with civic organizations to drive innovation that is fueled by a culture of belonging and a diverse workforce.
Today, Johnson & Jonson’s diversity & inclusion vision is for every person to use their unique experiences and backgrounds, together – to spark solutions that create a better, healthier world. Learn more: https://bit.ly/2SmYlWy
From a donation of a million masks to help protect vulnerable healthcare workers to committed research on a potential vaccine, the company has activated quickly in several key ways to help address the outbreak.
Article
In times of need, every bit of help counts.
It's something Johnson & Johnson knows well: Throughout its over 130-year history, the company has had a legacy of coming to the aid of local and global communities during times of crisis, from natural disasters to health outbreaks.
My mother always taught me about the importance of history and how critical it was to take steps to make your dreams come true. It may surprise you to learn that one of the things that inspired me to pursue my dreams was actually a roll of toilet paper!
At the World Economic Forum Annual Meeting in Davos, Johnson & Johnson announced a $250 million commitment to frontline health workers through the company's recently established Center for Health Worker Innovation.
It's the sixth leading cause of death in the United States, with no existing cure. But these researchers are committed to finding better ways to diagnose, treat and prevent the debilitating disease, using everything from innovative biomarker tracking to a potential vaccine for early stage patients.
Article
It's the sixth leading cause of death in the United States, with no existing cure. But these researchers are committed to finding better ways to diagnose, treat and prevent the debilitating disease, using everything from innovative biomarker tracking to a potential vaccine for early stage patients.
